People: Procter & Gamble Co (PG.N)

PG.N on New York Stock Exchange

83.11USD
29 Aug 2014
Price Change (% chg)

$0.08 (+0.10%)
Prev Close
$83.03
Open
$83.09
Day's High
$83.12
Day's Low
$82.60
Volume
1,774,939
Avg. Vol
1,877,422
52-wk High
$85.82
52-wk Low
$73.61

Search Stocks

Desmond-Hellmann, Susan 

Brief Biography

Dr. Susan Desmond-Hellmann, M.D., has been Independent Director of the Company. Dr. Desmond-Hellmann is Chancellor and Arthur and Toni Rembe Rock Distinguished Professor, University of California, San Francisco (“UCSF”), where she has served since August 2009. From 2004 through 2009, Dr. Desmond-Hellmann served as president of product development at Genentech (a biotechnology company), where she was responsible for pre-clinical and clinical development, business development, and product portfolio management. Prior to joining Genentech in 1995, Dr. Desmond-Hellmann was associate director of clinical cancer research at Bristol-Myers Squibb Pharmaceutical Research Institute. She has been a Director of Facebook Inc. since March 2013. As Chancellor of UCSF, a member of the Howard Hughes Medical Institute board of trustees, Facebook director, and past president of product development at Genentech, Dr. Desmond-Hellmann has extensive leadership and technology experience. As a former member of the Federal Reserve Bank of San Francisco’s Economic Advisory Council, she also brings finance experience to the Board.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alan Lafley

2,036,660

Werner Geissler

6,899,740

Jon Moeller

5,868,570

Steven Bishop

--

Giovanni Ciserani

--

Melanie Healey

--
As Of 29 Jun 2013
Search Stocks